- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/18 - Bridged systems
Patent holdings for IPC class C07D 487/18
Total number of patents in this class: 353
10-year publication summary
|
20
|
26
|
17
|
22
|
20
|
19
|
23
|
25
|
28
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi | 4243 |
27 |
| Bristol-myers Squibb Company | 4811 |
24 |
| UCB Biopharma SRL | 596 |
12 |
| Demerx, Inc. | 76 |
11 |
| Merck Patent GmbH | 5668 |
10 |
| Gilead Sciences, Inc. | 2189 |
7 |
| UCB Biopharma SPRL | 342 |
7 |
| Janssen Pharmaceutica N.V. | 3231 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2648 |
6 |
| Lumiphore, Inc. | 36 |
5 |
| Oncodesign S.A. | 16 |
5 |
| Sunovion Pharmaceuticals Inc. | 247 |
5 |
| Pathios Therapeutics Limited | 30 |
5 |
| Merck Sharp & Dohme LLC | 3729 |
5 |
| Forward Therapeutics, Inc. | 20 |
5 |
| F. Hoffmann-La Roche AG | 7837 |
4 |
| Abbott Laboratories | 2287 |
4 |
| Bayer Pharma AG | 1026 |
4 |
| Achillion Pharmaceuticals, Inc. | 159 |
4 |
| Ecolab USA Inc. | 5739 |
4 |
| Other owners | 193 |